Kailera Therapeutics, Inc. (KLRA) at a glance

Kailera Therapeutics, Inc. (KLRA) is a mid-cap Healthcare company. It trades at $15.65, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Momentum (7/100).

Price
$15.65
Market cap
$2.45B
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$16.37 to $28.23
Vestovix Score47/ 100How this works
Value
50
Growth
50
Income
40
Safety
66
Momentum
7

Other Healthcare stocks

See all